Modivcare INC 8-K filings

ModivCare Inc. successfully completed its financial restructuring, reducing funded debt by over 85% and securing $100 million in new capital, transitioning to private ownership.

ModivCare Inc. announced the immediate resignation of director David Mounts Gonzales, effective November 9, 2025, as its stock transitions to the OTC Expert Market.

Modivcare Inc. received a Nasdaq delisting notice and will have its common stock suspended following its voluntary Chapter 11 bankruptcy filing and delinquency in its quarterly report.

Modivcare Inc. has initiated voluntary Chapter 11 proceedings to implement a comprehensive financial restructuring, aiming to reduce its funded debt by approximately $1.1 billion and transition ownership to new investors.

ModivCare Inc. announced it has regained full compliance with Nasdaq's market value of publicly held shares requirement, ensuring its continued listing on The Nasdaq Global Select Market.

ModivCare Inc. announced that all proposed measures, including the election of seven directors and the approval of executive compensation, passed at its 2025 annual meeting of stockholders.

ModivCare Inc. announced the resignation of Chief People Officer Enrique Toledo, who will continue in a transitional role until June 27, 2025, with the company stating his departure is not due to any dispute.

ModivCare's Q1 2025 results show a revenue decrease and net loss, alongside a Nasdaq notification regarding its market value of publicly held shares falling below the required threshold.

Modivcare announces the departures of its CFO and CIO as part of a strategic shift towards a flatter, more automated organizational structure.

ModivCare Inc. appoints Daniel Silvers to its board of directors and announces the resignation of three directors, fulfilling obligations under its Fifth Amendment to the Credit Agreement.

ModivCare Inc. made its initial interest payment on its Second Lien Notes via payment-in-kind (PIK), increasing the aggregate principal amount outstanding.

ModivCare Inc. issues an additional $50.165 million in Second Lien Senior Secured PIK Toggle Notes due 2029, following stockholder approval of the Coliseum Transactions.

ModivCare Inc. amends its senior notes indenture, releasing guarantees and issuing second lien notes following an exchange agreement with certain noteholders.

ModivCare's Q4 2024 results show consistent service revenue year-over-year but a widened net loss, while the full year saw a slight revenue increase but a significant net loss, alongside the appointment of two new board members.

ModivCare Inc. has adjourned its Special Meeting of Stockholders to March 13, 2025, to ensure the release of its fourth quarter and full year 2024 financial results beforehand.

Modivcare Inc. will report its Q4 and full year 2024 financial results on March 6, 2025, and has adjourned its special stockholder meeting to March 13, 2025, to allow for the dissemination of these results.

Garth Graham resigned from ModivCare Inc.'s Board of Directors, effective February 28, 2025, with no reported disagreements with the company.

ModivCare Inc. appoints Erin L. Russell to its board of directors and announces the resignation of Neal Goldman, effective immediately.

ModivCare has obtained $105 million in new financing, appointed a Chief Transformation Officer, and is pursuing a strategic review of assets to improve its financial position and operational performance.

ModivCare Inc. has appointed Craig Barbarosh and Neal Goldman as independent directors to its board, effective December 23, 2024.

ModivCare Inc. reports the resignation of two board members and the appointment of an interim chair, effective December 13, 2024.

ModivCare's third-quarter results show a slight revenue increase and a net loss, while the company affirms its 2024 guidance and secures temporary debt covenant relief.

ModivCare has amended its credit agreement to increase its leverage ratio and reduce its interest coverage ratio for the quarter ended September 30, 2024, and has successfully collected $60 million in previously delayed contract receivables.

ModivCare has revised its 2024 Adjusted EBITDA guidance due to collection delays and strategic pricing adjustments, while projecting over 10% growth in 2025.

ModivCare Inc. files an 8-K to update its financials in anticipation of seeking additional capital, while also disclosing delays in collecting outstanding receivables.

ModivCare's second quarter results show consistent revenue year-over-year but a net loss, leading to a lowered adjusted EBITDA guidance for 2024.

ModivCare successfully refinanced its $500 million senior notes due in 2025 with a new $525 million term loan, enhancing financial flexibility.

ModivCare Inc. reports that all proposed measures, including the election of directors, were approved at the 2024 annual meeting of stockholders.

ModivCare Inc. has announced the resignation of Anne Bailey as President of Home, effective May 16, 2024, with a transition period planned until the end of June 2024.

ModivCare Inc. has published an investor presentation on its website in preparation for upcoming investor meetings.